Butasone Conc (Canada)This page contains information on Butasone Conc for veterinary use.
The information provided typically includes the following:
- Butasone Conc Indications
- Warnings and cautions for Butasone Conc
- Direction and dosage information for Butasone Conc
Butasone ConcThis treatment applies to the following species:
Each 30 g contains:
8 g (8,000 mg)
(1,2 Diphenyl, 4 Butyl, 3, 5 Pyrazolidinedione)
As an oral therapy in the treatment of arthritis myositis, inflammation and rheumatism in horses.
Note: One (1) level tablespoon contains approximately 10 g of powder containing 2.7 g of Phenylbutazone.
1 to 2 g of Phenylbutazone per 227 kg of body weight daily, in at least 2 divided doses. Daily dosage should not exceed 4 g. As symptoms regress, the dosage should be reduced to a level that will hold the condition in check. In some cases, treatment should be given only when symptoms appear with no need for continued medication. If there is not a significant clinical effect in five 5 days, a re-evaluation of the diagnosis and treatment should be made.
This drug is not to be administered to horses that are to be slaughtered for food.
Medication must be discontinued if signs of gastrointestinal upset or blood dyscrasia appear. Should not be administered to animals with cardiac, renal, or hepatic disease.
225 g jar
NAC No.: 12260160
510 ROWNTREE DAIRY ROAD, BUILDING "J", WOODBRIDGE, ON, L4L 8H2
|Every effort has been made to ensure the accuracy of the Butasone Conc information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-04-21